Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Feb 1.

Published in final edited form as: Menopause. 2018 Feb;25(2):191–196. doi: 10.1097/GME.0000000000000984

Table 1.

Participant demographics

	Placebo	50 mg	100 mg	P-value

N	6	6	6

Age, y mean (SD)	54.0 (2.2)	51.7 (2.9)	55.3 (3.8)	0.14^*

BMI, kg/m,² mean (SD),	26.3 (8.1)	27.9 (4.9)	28.3 (3.5)	0.81^*

Years since last menstrual period, mean (SD)	3.2 (1.3)	1.5 (0.9)	2.1 (1.6)	0.11^*

Race, n (%)
Asian	0	1 (16.7)	2 (33.3)	0.62^**
African American	1 (16.7)	1 (16.7)	1 (16.7)
White	5 (83.3)	3 (50.0)	2 (33.3)
Unknown	0	1 (16.7)	1 (16.7)

Hispanic, n (%)
Yes	1 (16.7)	1 (16.77)	2 (33.3)	0.72^**
No	5 (83.3)	5 (83.3)	4 (66.7)

^*

ANOVA,

^**

Fisher’s exact test